Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trafermin in Periodontal Tissue Regeneration
NCT00514657Phase 2Completed
- Sponsor
- Kaken Pharmaceutical Co., Ltd.
- Start
- Dec 2001
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 2 trial of trafermin in periodontitis, sponsored by Kaken Pharmaceutical Co., Ltd.. Started Dec 2001; status: completed.
02
Drugs
trafermin
03
Conditions
periodontitis
Beyond the preview
Go deeper on NCT00514657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00514657.